Fractional CO𝟐 laser therapy for vulvar lichen sclerosus in adults
Background: The CO2 laser has been used to treat vulvar lichen sclerosus (VLS) with a significant reduction in symptoms, and there is a paucity data on the efficacy, sexual function, and quality of life (QOL) improved. This study was to evaluate the efficacy of fractional CO2 laser for VLS and asses...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
IMR Press
2021-12-01
|
| Series: | Clinical and Experimental Obstetrics & Gynecology |
| Subjects: | |
| Online Access: | https://www.imrpress.com/journal/CEOG/48/6/10.31083/j.ceog4806211 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849324932684578816 |
|---|---|
| author | Xiaojuan Wang Yisong Chen Luwen Wang Zhong Lin Keqin Hua |
| author_facet | Xiaojuan Wang Yisong Chen Luwen Wang Zhong Lin Keqin Hua |
| author_sort | Xiaojuan Wang |
| collection | DOAJ |
| description | Background: The CO2 laser has been used to treat vulvar lichen sclerosus (VLS) with a significant reduction in symptoms, and there is a paucity data on the efficacy, sexual function, and quality of life (QOL) improved. This study was to evaluate the efficacy of fractional CO2 laser for VLS and assess sexual function and QOL from multi-centers. Methods: The women with biopsy-proved VLS who were treated with CO2 fractional laser were enrolled between January 2017 and December 2018 from three centers. The visual analogue scale (VAS) was to assess clinical symptoms. The Female sexual distress scale-revised (FSDS) was to evaluate the patients’ sexual activity, and the family Dermatology Life Quality Index (DLQI) was to evaluate the QOL. Results: A total of 119/122 patients (mean 44.5 years, 27–72 years) completed the treatment with fractional CO2 laser and following-up. The clinical symptoms and QOL were improved significantly from baseline to follow-up (3 months and 12 months post-treatment) according to the following measures: itching score, 7.65 (1.07, 0–10) versus 4.52 (1.23, 0–10) versus 0.96 (1.49, 0–4); burning score, 6.9 (1.66, 0–10) versus 3.82 (1.79, 0–8) versus 0.98 (1.42, 0–4); DLQL score, 14.24 (5.64, 0–30) versus 8.7 (1.9, 0–15) versus 5.7 (2.3, 0–10); FSDS score, 15.48 (11.3, 0–51) versus 12.51 (10.59, 0–45) versus 7.87 (9.34, 0–50). Conclusion: In conclusion, the fractional CO2laser was effective and safe for treating VLS, which significantly ameliorated the annoying symptoms and improved the quality of life. |
| format | Article |
| id | doaj-art-4bf5424445b445bab26676f8d7fbdcbe |
| institution | Kabale University |
| issn | 0390-6663 |
| language | English |
| publishDate | 2021-12-01 |
| publisher | IMR Press |
| record_format | Article |
| series | Clinical and Experimental Obstetrics & Gynecology |
| spelling | doaj-art-4bf5424445b445bab26676f8d7fbdcbe2025-08-20T03:48:32ZengIMR PressClinical and Experimental Obstetrics & Gynecology0390-66632021-12-014861330133410.31083/j.ceog4806211S0390-6663(21)01635-3Fractional CO𝟐 laser therapy for vulvar lichen sclerosus in adultsXiaojuan Wang0Yisong Chen1Luwen Wang2Zhong Lin3Keqin Hua4Department of Gynecology, Obstetrics and Gynecology Hospital, Fudan University, 200090 Shanghai, ChinaDepartment of Gynecology, Obstetrics and Gynecology Hospital, Fudan University, 200090 Shanghai, ChinaDepartment of Gynecology, The Third Affiliated Hospital of Zhengzhou University, 450015 Zhengzhou, Henan, ChinaDepartment of Gynecology, Liuzhou Maternal and Child Health Hospital, 545001 Liuzhou, Guangxi, ChinaDepartment of Gynecology, Obstetrics and Gynecology Hospital, Fudan University, 200090 Shanghai, ChinaBackground: The CO2 laser has been used to treat vulvar lichen sclerosus (VLS) with a significant reduction in symptoms, and there is a paucity data on the efficacy, sexual function, and quality of life (QOL) improved. This study was to evaluate the efficacy of fractional CO2 laser for VLS and assess sexual function and QOL from multi-centers. Methods: The women with biopsy-proved VLS who were treated with CO2 fractional laser were enrolled between January 2017 and December 2018 from three centers. The visual analogue scale (VAS) was to assess clinical symptoms. The Female sexual distress scale-revised (FSDS) was to evaluate the patients’ sexual activity, and the family Dermatology Life Quality Index (DLQI) was to evaluate the QOL. Results: A total of 119/122 patients (mean 44.5 years, 27–72 years) completed the treatment with fractional CO2 laser and following-up. The clinical symptoms and QOL were improved significantly from baseline to follow-up (3 months and 12 months post-treatment) according to the following measures: itching score, 7.65 (1.07, 0–10) versus 4.52 (1.23, 0–10) versus 0.96 (1.49, 0–4); burning score, 6.9 (1.66, 0–10) versus 3.82 (1.79, 0–8) versus 0.98 (1.42, 0–4); DLQL score, 14.24 (5.64, 0–30) versus 8.7 (1.9, 0–15) versus 5.7 (2.3, 0–10); FSDS score, 15.48 (11.3, 0–51) versus 12.51 (10.59, 0–45) versus 7.87 (9.34, 0–50). Conclusion: In conclusion, the fractional CO2laser was effective and safe for treating VLS, which significantly ameliorated the annoying symptoms and improved the quality of life.https://www.imrpress.com/journal/CEOG/48/6/10.31083/j.ceog4806211fractional co2 laservulvar lichen sclerosusefficacy |
| spellingShingle | Xiaojuan Wang Yisong Chen Luwen Wang Zhong Lin Keqin Hua Fractional CO𝟐 laser therapy for vulvar lichen sclerosus in adults Clinical and Experimental Obstetrics & Gynecology fractional co2 laser vulvar lichen sclerosus efficacy |
| title | Fractional CO𝟐 laser therapy for vulvar lichen sclerosus in adults |
| title_full | Fractional CO𝟐 laser therapy for vulvar lichen sclerosus in adults |
| title_fullStr | Fractional CO𝟐 laser therapy for vulvar lichen sclerosus in adults |
| title_full_unstemmed | Fractional CO𝟐 laser therapy for vulvar lichen sclerosus in adults |
| title_short | Fractional CO𝟐 laser therapy for vulvar lichen sclerosus in adults |
| title_sort | fractional co𝟐 laser therapy for vulvar lichen sclerosus in adults |
| topic | fractional co2 laser vulvar lichen sclerosus efficacy |
| url | https://www.imrpress.com/journal/CEOG/48/6/10.31083/j.ceog4806211 |
| work_keys_str_mv | AT xiaojuanwang fractionalco2lasertherapyforvulvarlichensclerosusinadults AT yisongchen fractionalco2lasertherapyforvulvarlichensclerosusinadults AT luwenwang fractionalco2lasertherapyforvulvarlichensclerosusinadults AT zhonglin fractionalco2lasertherapyforvulvarlichensclerosusinadults AT keqinhua fractionalco2lasertherapyforvulvarlichensclerosusinadults |